Skip to content
About
About us
Our Capabilities
Our Facility
Our Team
Work at IDT
Advanced Therapies
Aseptic Fill & Finish
mRNA – ADCs
Specialty Orals
Psychedelics/Medicinal Cannabis
Oral Finished Dose
API & Intermediates
Active Pharmaceutical Ingredients
Investors
ASX Announcements
Share Price
Corporate Governance
Investor Presentations
Annual Reports
News
Contact
News
Home
»
News
»
IDT – Whistleblower Policy
IDT – Whistleblower Policy
December 19, 2019
|
News
The policy can be viewed here
Posts navigation
← IDT – Whistleblower Policy_181219_FINAL
CAN and IDT announce commercial manufacture FINAL191219 →